We are thrilled to announce the release of the final newsletter of the NEOSETAC project, a groundbreaking initiative that has advanced the field of nanomedicine in cancer research. The project, funded by the European Union, has successfully brought together experts from various disciplines to address challenges and shape the future of cancer therapies. This newsletter highlights the significant milestones achieved throughout the project, including the final workshop, study visit, and project meeting.

NEOSETAC Final Workshop: Nanomedicine in Cancer Research
On September 26th, 2023, the NEOSETAC project conducted its final workshop at the prestigious University of Barcelona (UAB). The workshop focused on “Nanomedicine in Cancer Research: Overcoming Challenges and Shaping the Future of Therapies.” Esteemed researchers and experts in the field, both from academia and industry, participated in engaging discussions on various aspects of nanomedicine in cancer research. The workshop provided a platform for knowledge sharing, brainstorming, and collaborative networking, fostering innovative ideas and potential breakthroughs in cancer treatment.

NEOSETAC Study Visit to the Institute of Biotechnology and Biomedicine (IBB-UAB)
Continuing their commitment to promoting knowledge exchange, the NEOSETAC project organized a study visit to the renowned Institute of Biotechnology and Biomedicine (IBB-UAB) on September 28th, 2023. Participants had the opportunity to explore the state-of-the-art facilities, cutting-edge research projects, and technological advancements in nanomedicine and cancer research. This visit not only enriched participants’ understanding of emerging trends but also fostered collaborations and furthered advancements in therapeutic interventions.

NEOSETAC Final Project Meeting (General Assembly)
The NEOSETAC project’s final milestone, the General Assembly, took place on September 28th, 2023. This meeting brought together partners, collaborators, and stakeholders involved in the project to reflect on achievements, discuss outcomes, and assess the impact of the research endeavors. The event facilitated in-depth discussions on the future implications of the project’s findings and set the stage for continued efforts in advancing nanomedicine for cancer therapy.
The NEOSETAC project has been an incredible journey, pushing the boundaries of nanomedicine in cancer research. The final newsletter showcases the culmination of the project’s efforts, highlighting the successful final workshop, study visit to IBB-UAB, and the project meeting. By fostering collaboration, promoting knowledge exchange, and encouraging cutting-edge research, NEOSETAC has made significant contributions to the field of cancer therapy and opened new doors for further advancements.

Read NEOSETAC Final Newsletter press link below